CollPlant Biotechnologies Ltd - Ordinary Shares New

NASDAQ:CLGN  
6.77
+0.22 (+3.36%)
Earnings Announcements

Collplant Biotechnologies Posts Quarterly Loss Per Share Of $0.39

Published: 08/25/2022 11:36 GMT
CollPlant Biotechnologies Ltd - Ordinary Shares New (CLGN) - Collplant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results.
Collplant Biotechnologies Ltd - Qtrly Basic Loss per Share $0.39.
Collplant Biotechnologies Ltd - Qtrly Adjusted Loss per Share $0.36.
Revenue is expected to be $3.1 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $5.95 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.